Effectiveness and Safety of the RIGHTEST Continuous Glucose Monitoring System for Blood Glucose Management in Persons With Diabetes Mellitus

A trial with no phase registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 150 participants.

Also called NCT04838392

  • Study
  • In this atlas

Overview

Design
Interventional study; allocation not applicable; no masking; primary purpose treatment
Phase
Not applicable
Enrolled
  • 150 participants (planned count) (from the registry)
Sponsor
Bionime Corporation (from the registry)
Registry
  • NCT NCT04838392
Planned start
(anticipated) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
United States (from the registry)
Registry status
  • Unknown status (from the registry)

Technical summary

Registry record NCT04838392. Allocation not applicable; no masking; primary purpose treatment. Start 2024-12 (anticipated); primary completion 2025-07 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Effectiveness and Safety of the RIGHTEST Continuous Glucose Monitoring System for Blood Glucose Management in Persons With Diabetes Mellitus
Condition
Diabetes Mellitus
Condition
Type 1 Diabetes
Intervention (Device)
RIGHTEST Continuous Glucose Monitoring System
Lead sponsor
Bionime Corporation (class: industry)

Record details

Record id
cardio:ct-nct04838392
Content hash
4718f6b7af6211dbec5b1404b41a56305fa77a2d6583a940e44f9fd351a3b377